Display Settings:

Format

Send to:

Choose Destination
We are sorry, but NCBI web applications do not support your browser and may not function properly. More information
Science. 2009 Jun 26;324(5935):1664-5. doi: 10.1126/science.1171749.

Medical innovation versus stem cell tourism.

Author information

  • 1Laboratory of Neurogenesis and Cell Therapy, Wallenberg Neuroscience Center, and Lund Stem Cell Center, University Hospital, SE-221 84 Lund, Sweden. olle.lindvall@med.lu.se

Abstract

Stem cell tourism is criticized on grounds of consumer fraud, blatant lack of scientific justification, and patient safety. However, the issues are complex because they invoke questions concerning the limits of acceptable medical innovation and medical travel. Here we discuss these issues and articulate conditions under which "unproven" therapies may be offered to patients outside of regular clinical trials.

PMID:
19556497
[PubMed - indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Icon for HighWire
    Loading ...
    Write to the Help Desk